title: Commentary.
authors.affiliation: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, GA 30333, USA. bbranson@cdc.gov
authors.forename: Bernard M
authors.initials: BM
authors.lastname: Branson
mesh_terms: D015153:Blotting, Western; D003429:Cross Reactions; D005189:False Positive Reactions; D015483:HIV Antibodies / Q000097:blood*; D016655:HIV Core Protein p24 / Q000276:immunology; D019302:HIV Envelope Protein gp160 / Q000276:immunology; D015700:HIV Envelope Protein gp41 / Q000276:immunology; D006679:HIV Seropositivity / Q000175:diagnosis* / Q000276:immunology / Q000821:virology; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007118:Immunoassay; D012367:RNA, Viral / Q000032:analysis; D019562:Viral Load
chemical_list: D015483:HIV Antibodies; D016655:HIV Core Protein p24; D019302:HIV Envelope Protein gp160; D015700:HIV Envelope Protein gp41; D012367:RNA, Viral; C514787:gp41 protein, Human immunodeficiency virus 1